ReviewScientifica2013

Immune-mediated adverse events associated with ipilimumab ctla-4 blockade therapy: the underlying mechanisms and clinical management.

Ahmad TarhiniPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.